Movatterモバイル変換


[0]ホーム

URL:


Jump to content
WikipediaThe Free Encyclopedia
Search

1Z2MAP1O

From Wikipedia, the free encyclopedia

Pharmaceutical compound
1Z2MAP1O
Clinical data
Other names1-(Indolizin-3-yl)-2-(methylamino)propan-1-one; Structure XLX
Drug classMonoamine releasing agent;Serotonin5-HT1B receptoragonist;Serotonin5-HT2B receptorantagonist;Entactogen
Identifiers
  • 1-indolizin-3-yl-2-(methylamino)propan-1-one
CAS Number
PubChemCID
ChemSpider
Chemical and physical data
FormulaC12H14N2O
Molar mass202.257 g·mol−1
3D model (JSmol)
  • CC(C(=O)C1=CC=C2N1C=CC=C2)NC
  • InChI=1S/C12H14N2O/c1-9(13-2)12(15)11-7-6-10-5-3-4-8-14(10)11/h3-9,13H,1-2H3
  • Key:BFSFBVDVCJVAMW-UHFFFAOYSA-N

1Z2MAP1O, also known as1-(indolizin-3-yl)-2-(methylamino)propan-1-one, is amonoamine releasing agent andserotonin receptormodulator of theindolizinylethylamine family.[1] It is ananalogue ofBK-NM-AMT (β-keto-N-methyl-α-methyltryptamine) in which theindolering has been replaced with anindolizine ring.[1]

1Z2MAP1O has been found to be aserotonin anddopamine releasing agent as well as a weakserotonin5-HT1B receptoragonist and serotonin5-HT2B receptorantagonist.[1] Conversely, its activity as anorepinephrine releasing agent was not reported, and it was inactive at the remaining sites of the 47 screenedtargets.[1] The drug'sEC50Tooltip half-maximal effective concentration values for induction of monoamine release were 109 nM for serotonin and 227 nM fordopamine inChinese hamster ovary (CHO)cells expressing the humanmonoamine transporters (MATs).[1] The dopamine/serotonin ratio was 0.48.[1] ItsEC50 at the serotonin 5-HT1B receptor was 1,130 nM, whereas itsIC50Tooltip half-maximal inhibitory concentration values were 2,140 nM at the serotonin 5-HT2B receptor, 2,410 nM at thedopamine transporter (DAT), and 5,690 nM at thenorepinephrine transporter (NET).[1] 1Z2MAP1O's inhibition of theserotonin transporter (SERT) was not reported.[1]

1Z2MAP1O waspatented byMatthew Baggott ofTactogen in 2023.[1]

See also

[edit]

References

[edit]
  1. ^abcdefghiWO application 2023081306A1, Baggott MJ, "Indolizine compounds for the treatment of mental disorders or mental enhancement", published 11 May 2023, assigned toTactogen 

External links

[edit]
Phenethylamines
Non-ring-extended
Benzodioxoles
(methylenedioxy- or MDxx)
Benzodioxines
(ethylenedioxy-)
Benzofurans
Dihydrobenzofurans
Benzothiophenes
Benzothiazoles
Benzoxathioles
Indanes
Indoles
Naphthalenes
Tetralins
Others
Cyclized
phenethylamines
2-Aminoindanes
1-Aminomethylindanes
2-Aminotetralins
Aminorexes
Tryptamines
α-Alkyltryptamines
Others
Benzofurans
Benzothiophenes
Indolizines
Isotryptamines
Others
DRAsTooltip Dopamine releasing agents
NRAsTooltip Norepinephrine releasing agents
SRAsTooltip Serotonin releasing agents
Others
5-HT1
5-HT1A
5-HT1B
5-HT1D
5-HT1E
5-HT1F
5-HT2
5-HT2A
5-HT2B
5-HT2C
5-HT37
5-HT3
5-HT4
5-HT5A
5-HT6
5-HT7
Stub icon

Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it.

Retrieved from "https://en.wikipedia.org/w/index.php?title=1Z2MAP1O&oldid=1322837291"
Categories:
Hidden categories:

[8]ページ先頭

©2009-2025 Movatter.jp